Polyadenylate Polymerase (PAP) and 3' End pre-mRNA Processing: Function, Assays, and Association with Disease

References

• Jacob ST, Terns MP, Maguire KA. Polyadenylate polymerases from normal and cancer cells and their potential role in messenger RNA processing: a review. Cancer Res 1989; 49: 2827–33.
   PubMedGoogle Scholar
• Huang Y, Carmichael GC. Role of polyadenylation in nucleocytoplasmic transport of mRNA. Mol Cell Biol 1996; 16: 1534–42.
   PubMed Web of Science ®Google Scholar
• Eckner R, Ellmeier W, Birnstiel ML. Mature mRNA 3' end formation stimulates RNA export from the nucleus. EMBO J 1991; 10: 3513–22.
   PubMed Web of Science ®Google Scholar
• Colgan DF, Manley JL. Mechanism and regulation of mRNA polyadenylation. Genes Dev 1997; 11: 2755–66.
   PubMed Web of Science ®Google Scholar
• Preiss T, Hentze MW. Dual function of the messenger RNA cap structure in poly(A)-tail-promoted translation in yeast. Nature 1998; 392: 516–20.
   PubMedGoogle Scholar
• Richter JD. Cytoplasmic polyadenylation in development and beyond. Microbiol Mol Biol Rev 1999; 63: 446–56.
   PubMedGoogle Scholar
• Sachs AB, Sarnow P, Hentze MW. Starting at the beginning, middle, and end: translation initiation in eukaryotes. Cell 1997; 89: 831–8.
   PubMed Web of Science ®Google Scholar
• Beelman CA, Parker R. Degradation of mRNA in eukaryotes. Cell 1995; 81: 179–83.
   PubMed Web of Science ®Google Scholar
• Ford LP, Bagga PS, Wilusz J. The poly(A) tail inhibits the assembly of a 3'-to-5' exonuclease in an in vitro RNA stability system. Mol Cell Biol 1997; 17: 398–406.
   PubMedGoogle Scholar
• Wickens M, Anderson P, Jackson RJ. Life and death in the cytoplasm: messages from the 3' end. Curr Opin Genet Dev 1997; 7: 220–32.
   PubMed Web of Science ®Google Scholar
• Ingle CA, Kushner SR. Development of an in vitro mRNA decay system for Escherichia coli: poly(A) polymerase I is necessary to trigger degradation. Proc Natl Acad Sci U S A 1996; 93: 12926–31.
   PubMedGoogle Scholar
• Takagaki Y, Manley JL. Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation. Mol Cell 1998; 2: 761–71.
   PubMed Web of Science ®Google Scholar
• Zhao W, Manley JL. Complex alternative RNA processing generates an unexpected diversity of poly(A) polymerase isoforms. Mol Cell Biol 1996; 16: 2378–86.
   PubMedGoogle Scholar
• Brais B, Bouchard JP, Xie YG, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 1998; 18: 164–7.
   PubMed Web of Science ®Google Scholar
• Gieselmann V, Polten A, Kreysing J, von Figura K. Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. Proc Natl Acad Sci USA 1989; 86: 9436–40.
   PubMed Web of Science ®Google Scholar
• Higgs DR, Goodbourn SE, Lamb J, et al. Alpha-thalassaemia caused by a polyadenylation signal mutation. Nature 1983; 306: 398–400.
   PubMed Web of Science ®Google Scholar
• Orkin SH, Cheng TC, Antonarakis SE, et al. Thalassemia due to a mutation in the cleavage-polyadenylation signal of the human beta-globin gene. EMBO J 1985; 4: 453–6.
   PubMed Web of Science ®Google Scholar
• Lin CL, Bristol LA, Jin L, et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589–602.
   PubMed Web of Science ®Google Scholar
• Sachs A, Wahle E. Poly(A) tail metabolism and function in eucaryotes. J Biol Chem 1993; 268: 22955–8.
   PubMed Web of Science ®Google Scholar
• Lutz CS, Murthy KG, Schek N, et al. Interaction between the U1 snRNP-A protein and the 160-kD subunit of cleavage-polyadenylation specificity factor increases polyadenylation efficiency in vitro. Genes Dev 1996; 10: 325–37.
   PubMed Web of Science ®Google Scholar
• Pinol-Roma S, Dreyfuss G. Transcription-dependent and transcription-independent nuclear transport of hnRNP proteins. Science 1991; 253: 312–4.
   PubMed Web of Science ®Google Scholar
• Scorilas A, Black MH, Talieri M, et al. Genomic organization, physical mapping, and expression analysis of the human protein arginine methyltransferase 1 gene. Biochem Biophys Res Commun 2000; 278: 349–59.
   PubMed Web of Science ®Google Scholar
• Soulard M, Della Valle V, Siomi MC, et al. hnRNP G: sequence and characterization of a glycosylated RNA-binding protein. Nucleic Acids Res 1993; 21: 4210–7.
   PubMed Web of Science ®Google Scholar
• MacDonald CC, Wilusz J, Shenk T. The 64-kilodalton subunit of the CstF polyadenylation factor binds to pre-mRNAs downstream of the cleavage site and influences cleavage site location. Mol Cell Biol 1994; 14: 6647–54.
   PubMed Web of Science ®Google Scholar
• Zhao J, Hyman L, Moore C. Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 1999; 63: 405–45.
   PubMed Web of Science ®Google Scholar
• Kyriakopoulou CB, Nordvarg H, Virtanen A. A novel nuclear human poly(A) polymerase (PAP), PAP gamma. J Biol Chem 2001; 276: 33504–11.
   PubMedGoogle Scholar
• Scorilas A, Kyriakopoulou L, Katsaros D, et al. Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer. Br J Cancer 2001; 85: 190–8.
   PubMed Web of Science ®Google Scholar
• Ameisen JC. Programmed cell death (apoptosis) and cell survival regulation: relevance to AIDS and cancer. AIDS 1994; 8: 1197–213.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Petit P, Zamzami N, et al. The biochemistry of programmed cell death. FASEB J 1995; 9: 1277–87.
   PubMed Web of Science ®Google Scholar
• Scorilas A, Kyriakopoulou L, Yousef GM, et al. Molecular cloning, physical mapping, and expression analysis of a novel gene, bcl2l12, encoding a proline-rich protein with a highly conserved bh2 domain of the bcl-2 family. Genomics 2001; 72: 217–21.
   PubMed Web of Science ®Google Scholar
• Atabasides H, Tsiapalis CM, Havredaki M. Dephosphorylation, proteolysis, and reduced activity of poly(A) polymerase associated with U937 cell apoptosis. Exp Cell Res 1998; 244: 433–40.
   PubMedGoogle Scholar
• Proudfoot N. Poly(A) signals. Cell 1991; 64: 671–4.
   PubMedGoogle Scholar
• Magklara A, Scorilas A, Katsaros D, et al. The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer. Clin Cancer Res 2001; 7: 806–11.
   PubMed Web of Science ®Google Scholar
• Yousef GM, Scorilas A, Jung K, et al. Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer. J Biol Chem 2001; 276: 53–61.
   PubMed Web of Science ®Google Scholar
• Kim H, Scorilas A, Katsaros D, et al. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br J Cancer 2001; 84: 643–50.
   PubMed Web of Science ®Google Scholar
• Luo LY, Bunting P, Scorilas A, Diamandis EP. Human kallikrein 10: a novel tumor marker for ovarian carcinoma? Clin Chim Acta 2001; 306: 111–8.
   PubMed Web of Science ®Google Scholar
• Yousef GM, Chang A, Scorilas A, et al. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem Biophys Res Commun 2000; 276: 125–33.
   PubMed Web of Science ®Google Scholar
• Yousef GM, Scorilas A, Magklara A, et al. The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family — genomic characterization, mapping, tissue expression and hormonal regulation. Gene 2000; 254: 119–28.
   PubMed Web of Science ®Google Scholar
• Yousef GM, Scorilas A, Diamandis EP. Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family. Genomics 2000; 63: 88–96.
   PubMed Web of Science ®Google Scholar
• Manley JL. Polyadenylation of mRNA precursors. Biochim Biophys Acta 1988; 950: 1–12.
   PubMedGoogle Scholar
• Sheets MD, Ogg SC, Wickens MP. Point mutations in AAUAAA and the poly (A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro. Nucleic Acids Res 1990; 18: 5799–805.
   PubMed Web of Science ®Google Scholar
• Wahle E, Keller W. The biochemistry of 3'-end cleavage and polyadenylation of messenger RNA precursors. Annu Rev Biochem 1992; 61: 419–40.
   PubMed Web of Science ®Google Scholar
• Wells D, Kedes L. Structure of a human histone cDNA: evidence that basally expressed histone genes have intervening sequences and encode polyadenylylated mRNAs. Proc Natl Acad Sci USA 1985; 82: 2834–8.
   PubMedGoogle Scholar
• Wickens M. How the messenger got its tail: addition of poly(A) in the nucleus. Trends Biochem Sci 1990; 15: 277–81.
   PubMed Web of Science ®Google Scholar
• Wilusz J, Pettine SM, Shenk T. Functional analysis of point mutations in the AAUAAA motif of the SV40 late polyadenylation signal. Nucleic Acids Res 1989; 17: 3899–908.
   PubMedGoogle Scholar
• Hook AG, Kellems RE. Localization and sequence analysis of poly(A) sites generating multiple dihydrofolate reductase mRNAs. J Biol Chem 1988; 263: 2337–43.
   PubMedGoogle Scholar
• Setzer DR, McGrogan M, Nunberg JH, et al. Size heterogeneity in the 3' end of dihydrofolate reductase messenger RNAs in mouse cells. Cell 1980; 22: 361–70.
   PubMed Web of Science ®Google Scholar
• Wallace AM, Dass B, Ravnik SE, et al. Two distinct forms of the 64,000 Mr protein of the cleavage stimulation factor are expressed in mouse male germ cells. Proc Natl Acad Sci USA 1999; 96: 6763–8.
   PubMedGoogle Scholar
• Challoner PB, Moss SB, Groudine M. Expression of replication-dependent histone genes in avian spermatids involves an alternate pathway of mRNA 3'-end formation. Mol Cell Biol 1989; 9: 902–13.
   PubMedGoogle Scholar
• Zarkower D, Wickens M. A functionally redundant downstream sequence in SV40 late pre-mRNA is required for mRNA 3'-end formation and for assembly of a precleavage complex in vitro. J Biol Chem 1988; 263: 5780–8.
   PubMedGoogle Scholar
• Mason PJ, Elkington JA, Lloyd MM, Jones MB, Williams JG. Mutations downstream of the polyadenylation site of a Xenopus beta-globin mRNA affect the position but not the efficiency of 3' processing. Cell 1986; 46: 263–70.
   PubMedGoogle Scholar
• Gil A, Proudfoot NJ. Position-dependent sequence elements downstream of AAUAAA are required for efficient rabbit beta-globin mRNA 3' end formation. Cell 1987; 49: 399–406.
   PubMed Web of Science ®Google Scholar
• Chen F, MacDonald CC, Wilusz J. Cleavage site determinants in the mammalian polyadenylation signal. Nucleic Acids Res 1995; 23: 2614–20.
   PubMed Web of Science ®Google Scholar
• Chou ZF, Chen F, Wilusz J. Sequence and position requirements for uridylate-rich downstream elements of polyadenylation signals. Nucleic Acids Res 1994; 22: 2525–31.
   PubMedGoogle Scholar
• McLauchlan J, Gaffney D, Whitton JL, et al. The consensus sequence YGTGTTYY located downstream from the AATAAA signal is required for efficient formation of mRNA 3' termini. Nucleic Acids Res 1985; 13: 1347–68.
   PubMed Web of Science ®Google Scholar
• Moreira A, Wollerton M, Monks J, et al. Upstream sequence elements enhance poly(A) site efficiency of the C2 complement gene and are phylogenetically conserved. EMBO J 1995; 14: 3809–19.
   PubMed Web of Science ®Google Scholar
• Moreira A, Takagaki Y, Brackenridge S, et al. The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3' end formation by two distinct mechanisms. Genes Dev 1998; 12: 2522–34.
   PubMed Web of Science ®Google Scholar
• Valsamakis A, Zeichner S, Carswell S, et al. The human immunodeficiency virus type 1 polyadenylylation signal: a 3' long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylylation. Proc Natl Acad Sci USA 1991; 88: 2108–12.
   PubMed Web of Science ®Google Scholar
• Schek N, Cooke C, Alwine JC. Definition of the upstream efficiency element of the simian virus 40 late polyadenylation signal by using in vitro analyses. Mol Cell Biol 1992; 12: 5386–93.
   PubMed Web of Science ®Google Scholar
• Lutz CS, Alwine JC. Direct interaction of the U1 snRNP-A protein with the upstream efficiency element of the SV40 late polyadenylation signal. Genes Dev 1994; 8: 576–86.
   PubMed Web of Science ®Google Scholar
• Prescott JC, Falck-Pedersen E. Varied poly(A) site efficiency in the adenovirus major late transcription unit. J Biol Chem 1992; 267: 8175–81.
   PubMedGoogle Scholar
• Prescott J, Falck-Pedersen E. Sequence elements upstream of the 3' cleavage site confer substrate strength to the adenovirus L1 and L3 polyadenylation sites. Mol Cell Biol 1994; 14: 4682–93.
   PubMedGoogle Scholar
• Silver Key SC, Pagano JS. A noncanonical poly(A) signal, UAUAAA, and flanking elements in Epstein-Barr virus DNA polymerase mRNA function in cleavage and polyadenylation assays. Virology 1997; 234: 147–59.
   PubMedGoogle Scholar
• Sittler A, Gallinaro H, Jacob M. Upstream and downstream cis-acting elements for cleavage at the L4 polyadenylation site of adenovirus-2. Nucleic Acids Res 1994; 22: 222–31.
   PubMedGoogle Scholar
• Wahle E, Kuhn U. The mechanism of 3' cleavage and polyadenylation of eukaryotic pre-mRNA. Prog Nucleic Acid Res Mol Biol 1997; 57: 41–71.
   PubMedGoogle Scholar
• Verrotti AC, Thompson SR, Wreden C, et al. Evolutionary conservation of sequence elements controlling cytoplasmic polyadenylylation. Proc Natl Acad Sci U S A 1996; 93: 9027–32.
   PubMedGoogle Scholar
• Bardwell VJ, Wickens M, Bienroth S, et al. Site-directed ribose methylation identifies 2'-OH groups in polyadenylation substrates critical for AAUAAA recognition and poly(A) addition. Cell 1991; 65: 125–33.
   PubMedGoogle Scholar
• Bienroth S, Wahle E, Suter-Crazzolara C, et al. Purification of the cleavage and polyadenylation factor involved in the 3'-processing of messenger RNA precursors. J Biol Chem 1991; 266: 19768–76.
   PubMed Web of Science ®Google Scholar
• Gilmartin GM, Nevins JR. Molecular analyses of two poly(A) site-processing factors that determine the recognition and efficiency of cleavage of the pre-mRNA. Mol Cell Biol 1991; 11: 2432–8.
   PubMed Web of Science ®Google Scholar
• Keller W, Bienroth S, Lang KM, et al. Cleavage and polyadenylation factor CPF specifically interacts with the pre-mRNA 3' processing signal AAUAAA. EMBO J 1991; 10: 4241–9.
   PubMed Web of Science ®Google Scholar
• Weiss EA, Gilmartin GM, Nevins JR. Poly(A) site efficiency reflects the stability of complex formation involving the downstream element. EMBO J 1991; 10: 215–9.
   PubMedGoogle Scholar
• Jenny A, Hauri HP, Keller W. Characterization of cleavage and polyadenylation specificity factor and cloning of its 100-kilodalton subunit. Mol Cell Biol 1994; 14: 8183–90.
   PubMedGoogle Scholar
• Murthy KG, Manley JL. Characterization of the multisubunit cleavage-polyadenylation specificity factor from calf thymus. J Biol Chem 1992; 267: 14804–11.
   PubMed Web of Science ®Google Scholar
• Murthy KG, Manley JL. The 160-kD subunit of human cleavage-polyadenylation specificity factor coordinates pre-mRNA 3'-end formation. Genes Dev 1995; 9: 2672–83.
   PubMedGoogle Scholar
• Jenny A, Keller W. Cloning of cDNAs encoding the 160 kDa subunit of the bovine cleavage and polyadenylation specificity factor. Nucleic Acids Res 1995; 23: 2629–35.
   PubMedGoogle Scholar
• Burd CG, Dreyfuss G. Conserved structures and diversity of functions of RNA-binding proteins. Science 1994; 265: 615–21.
   PubMed Web of Science ®Google Scholar
• Nagai K. RNA-protein complexes. Curr Opin Struct Biol 1996; 6: 53–61.
   PubMed Web of Science ®Google Scholar
• Chen EJ, Frand AR, Chitouras E, et al. A link between secretion and pre-mRNA processing defects in Saccharomyces cerevisiae and the identification of a novel splicing gene, RSE1. Mol Cell Biol 1998; 18: 7139–46.
   PubMedGoogle Scholar
• Barabino SM, Hubner W, Jenny A, et al. The 30-kDa subunit of mammalian cleavage and polyadenylation specificity factor and its yeast homolog are RNA-binding zinc finger proteins. Genes Dev 1997; 11: 1703–16.
   PubMedGoogle Scholar
• Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505–10.
   PubMed Web of Science ®Google Scholar
• Bai C, Tolias PP. Drosophila clipper/CPSF 30K is a post-transcriptionally regulated nuclear protein that binds RNA containing GC clusters. Nucleic Acids Res 1998; 26: 1597–604.
   PubMed Web of Science ®Google Scholar
• Jenny A, Minvielle-Sebastia L, Preker PJ, et al. Sequence similarity between the 73-kilodalton protein of mammalian CPSF and a subunit of yeast polyadenylation factor I. Science 1996; 274: 1514–7.
   PubMedGoogle Scholar
• Takagaki Y, Manley JL, MacDonald CC, et al. A multisubunit factor, CstF, is required for polyadenylation of mammalian pre-mRNAs. Genes Dev 1990; 4: 2112–20.
   PubMed Web of Science ®Google Scholar
• Takagaki Y, Manley JL. A polyadenylation factor subunit is the human homologue of the Drosophila suppressor of forked protein. Nature 1994; 372: 471–4.
   PubMed Web of Science ®Google Scholar
• Takagaki Y, MacDonald CC, Shenk T, et al. The human 64-kDa polyadenylylation factor contains a ribonucleoprotein-type RNA binding domain and unusual auxiliary motifs. Proc Natl Acad Sci USA 1992; 89: 1403–7.
   PubMedGoogle Scholar
• Takagaki Y, Seipelt RL, Peterson ML, et al. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 1996; 87: 941–52.
   PubMed Web of Science ®Google Scholar
• Zhao W, Manley JL. Deregulation of poly(A) polymerase interferes with cell growth. Mol Cell Biol 1998; 18: 5010–20.
   PubMedGoogle Scholar
• Preker PJ, Keller W. The HAT helix, a repetitive motif implicated in RNA processing. Trends Biochem Sci 1998; 23: 15–6.
   PubMed Web of Science ®Google Scholar
• Takagaki Y, Manley JL. A human polyadenylation factor is a G protein beta-subunit homo-logue. J Biol Chem 1992; 267: 23471–4.
   PubMed Web of Science ®Google Scholar
• Steinmetz EJ, Brow DA. Control of pre-mRNA accumulation by the essential yeast protein Nrd1 requires high-affinity transcript binding and a domain implicated in RNA polymerase II association. Proc Natl Acad Sci USA 1998; 95: 6699–704.
   PubMed Web of Science ®Google Scholar
• McLean MR, Rymond BC. Yeast pre-mRNA splicing requires a pair of U1 snRNP-associated tetratricopeptide repeat proteins. Mol Cell Biol 1998; 18: 353–60.
   PubMedGoogle Scholar
• Takagaki Y, Ryner LC, Manley JL. Four factors are required for 3'-end cleavage of pre-mRNAs. Genes Dev 1989; 3: 1711–24.
   PubMed Web of Science ®Google Scholar
• Ruegsegger U, Beyer K, Keller W. Purification and characterization of human cleavage factor Im involved in the 3' end processing of messenger RNA precursors. J Biol Chem 1996; 271: 6107–13.
   PubMed Web of Science ®Google Scholar
• Ruegsegger U, Blank D, Keller W. Human pre-mRNA cleavage factor Im is related to spliceosomal SR proteins and can be reconstituted in vitro from recombinant subunits. Mol Cell 1998; 1: 243–53.
   PubMed Web of Science ®Google Scholar
• Wahle E, Ruegsegger U. 3'-end processing of pre-mRNA in eukaryotes. FEMS Microbiol Rev 1999; 23: 277–95.
   PubMed Web of Science ®Google Scholar
• McCracken S, Fong N, Yankulov K, et al. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 1997; 385: 357–61.
   PubMed Web of Science ®Google Scholar
• Hirose Y, Manley JL. RNA polymerase II is an essential mRNA polyadenylation factor. Nature 1998; 395: 93–6.
   PubMed Web of Science ®Google Scholar
• Bentley D. Coupling RNA polymerase II transcription with pre-mRNA processing. Curr Opin Cell Biol 1999; 11: 347–51.
   PubMedGoogle Scholar
• Raabe T, Bollum FJ, Manley JL. Primary structure and expression of bovine poly(A) poly-merase. Nature 1991; 353: 229–34.
   PubMedGoogle Scholar
• Wahle E. Purification and characterization of a mammalian polyadenylate polymerase involved in the 3' end processing of messenger RNA precursors. J Biol Chem 1991; 266: 3131–9.
   PubMedGoogle Scholar
• Wahle E, Martin G, Schiltz E, et al. Isolation and expression of cDNA clones encoding mammalian poly(A) polymerase. EMBO J 1991; 10: 4251–7.
   PubMed Web of Science ®Google Scholar
• Bienroth S, Keller W, Wahle E. Assembly of a processive messenger RNA polyadenylation complex. EMBO J 1993; 12: 585–94.
   PubMed Web of Science ®Google Scholar
• Wahle E, Keller W. RNA-protein interactions in mRNA 3'-end formation. Mol Biol Rep 1993; 18: 157–61.
   PubMedGoogle Scholar
• Colgan DF, Murthy KG, Zhao W, et al. Inhibition of poly(A) polymerase requires p34cdc2/ cyclin B phosphorylation of multiple consensus and non-consensus sites. EMBO J 1998; 17: 1053–62.
   PubMed Web of Science ®Google Scholar
• Thuresson AC, Astrom J, Astrom A, et al. Multiple forms of poly(A) polymerases in human cells. Proc Natl Acad Sci USA 1994; 91: 979–83.
   PubMedGoogle Scholar
• Ballantyne S, Bilger A, Astrom J, et al. Poly (A) polymerases in the nucleus and cytoplasm of frog oocytes: dynamic changes during oocyte maturation and early development. RNA 1995; 1: 64–78.
   PubMedGoogle Scholar
• Lingner J, Kellermann J, Keller W. Cloning and expression of the essential gene for poly(A) polymerase from S. cerevisiae. Nature 1991; 354: 496–8.
   Google Scholar
• Ohnacker M, Minvielle-Sebastia L, Keller W. The Schizosaccharomyces pombe pla1 gene encodes a poly(A) polymerase and can functionally replace its Saccharomyces cerevisiae homologue. Nucleic Acids Res 1996; 24: 2585–91.
   PubMedGoogle Scholar
• Cao GJ, Sarkar N. Identification of the gene for an Escherichia coli poly(A) polymerase. Proc Natl Acad Sci USA 1992; 89: 10380–4.
   PubMed Web of Science ®Google Scholar
• Juge F, Audibert A, Benoit B, Simonelig M. Tissue-specific autoregulation of Drosophila suppressor of forked by alternative poly(A) site utilization leads to accumulation of the suppressor of forked protein in mitotically active cells. RNA 2000; 6: 1529–38.
   Google Scholar
• Gershon PD, Ahn BY, Garfield M, Moss B. Poly(A) polymerase and a dissociable polyadenylation stimulatory factor encoded by vaccinia virus. Cell 1991; 66: 1269–78.
   PubMedGoogle Scholar
• Kashiwabara S, Zhuang T, Yamagata K, et al. Identification of a novel isoform of poly(A) polymerase, TPAP, specifically present in the cytoplasm of spermatogenic cells. Dev Biol 2000; 228: 106–15.
   PubMed Web of Science ®Google Scholar
• Gebauer F, Richter JD. Cloning and characterization of a Xenopus poly(A) polymerase. Mol Cell Biol 1995; 15: 1422–30.
   PubMedGoogle Scholar
• Yamauchi T, Sugimoto J, Hatakeyama T, et al. Assignment of the human poly(A) polymerase (PAP) gene to chromosome 14q32.1-q32.2 and isolation of a polymorphic CA repeat sequence. J Hum Genet 1999; 44: 253–5.
   PubMedGoogle Scholar
• Lee YJ, Lee Y, Chung JH. An intronless gene encoding a poly(A) polymerase is specifically expressed in testis. FEBS Lett 2000; 487: 287–92.
   PubMedGoogle Scholar
• Scorilas A, Yousef GM, Jung K, Rajpert-De Meyts E, et al. Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors. Biochem Biophys Res Commun 2001; 285: 400–8.
   PubMedGoogle Scholar
• Takagaki Y, Ryner LC, Manley JL. Separation and characterization of a poly(A) polymerase and a cleavage/specificity factor required for pre-mRNA polyadenylation. Cell 1988; 52: 731–42.
   PubMed Web of Science ®Google Scholar
• Martin G, Keller W, Doublie S. Crystal structure of mammalian poly(A) polymerase in complex with an analog of ATP. EMBO J 2000; 19: 4193–203.
   PubMed Web of Science ®Google Scholar
• Martin G, Keller W. Mutational analysis of mammalian poly(A) polymerase identifies a region for primer binding and catalytic domain, homologous to the family X polymerases, and to other nucleotidyltransferases. EMBO J 1996; 15: 2593–603.
   PubMed Web of Science ®Google Scholar
• Martin F, Schaller A, Eglite S, et al. The gene for histone RNA hairpin binding protein is located on human chromosome 4 and encodes a novel type of RNA binding protein. EMBO J 1997; 16: 769–78.
   PubMedGoogle Scholar
• Raju VS, Jacob ST. Association of poly(A) polymerase with U1 RNA. J Biol Chem 1988; 263: 11067–70.
   PubMedGoogle Scholar
• Holm L, Sander C. DNA polymerase beta belongs to an ancient nucleotidyltransferase super-family. Trends Biochem Sci 1995; 20: 345–7.
   PubMed Web of Science ®Google Scholar
• Vagner S, Ruegsegger U, Gunderson SI, et al. Position-dependent inhibition of the cleavage step of pre-mRNA 3'-end processing by U1 snRNP. RNA 2000; 6: 178–88.
   PubMed Web of Science ®Google Scholar
• Gunderson SI, Polycarpou-Schwarz M, Mattaj IW. U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. Mol Cell 1998; 1: 255–64.
   PubMed Web of Science ®Google Scholar
• Gunderson SI, Beyer K, Martin G, et al. The human U1A snRNP protein regulates polyadenylation via a direct interaction with poly(A) polymerase. Cell 1994; 76: 531–41.
   PubMed Web of Science ®Google Scholar
• Wittmann T, Wahle E. Purification and characterization of full-length mammalian poly(A) polymerase. Biochim Biophys Acta 1997; 1350: 293–305.
   PubMedGoogle Scholar
• Bard J, Zhelkovsky AM, Helmling S, et al. Structure of yeast poly(A) polymerase alone and in complex with 3'-dATP. Science 2000; 289: 1346–9.
   PubMedGoogle Scholar
• Wahle E, Lustig A, Jeno P, et al. Mammalian poly(A)-binding protein II. Physical properties and binding to polynucleotides. J Biol Chem 1993; 268: 2937–45.
   PubMedGoogle Scholar
• Nemeth A, Krause S, Blank D, et al. Isolation of genomic and cDNA clones encoding bovine poly(A) binding protein II. Nucleic Acids Res 1995; 23: 4034–41.
   PubMedGoogle Scholar
• Chen Z, Li Y, Krug RM. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J 1999; 18: 2273–83.
   PubMed Web of Science ®Google Scholar
• Sarkar N. Polyadenylation of mRNA in prokaryotes. Annu Rev Biochem 1997; 66: 173–97.
   PubMed Web of Science ®Google Scholar
• Wang ZF, Tisovec R, Debry RW, et al. Characterization of the 55-kb mouse histone gene cluster on chromosome 3. Genome Res 1996; 6: 702–14.
   PubMedGoogle Scholar
• Muller B, Schumperli D. The U7 snRNP and the hairpin binding protein: key players in histone mRNA metabolism. Semin Cell Dev Biol 1997; 8: 567–76.
   PubMed Web of Science ®Google Scholar
• Bond UM, Yario TA, Steitz JA. Multiple processing-defective mutations in a mammalian histone pre-mRNA are suppressed by compensatory changes in U7 RNA both in vivo and in vitro. Genes Dev 1991; 5: 1709–22.
   PubMed Web of Science ®Google Scholar
• Wang ZF, Whitfield ML, Ingledue TC, et al. The protein that binds the 3' end of histone mRNA: a novel RNA-binding protein required for histone pre-mRNA processing. Genes Dev 1996; 10: 3028–40.
   PubMed Web of Science ®Google Scholar
• Colgan DF, Murthy KG, Prives C, et al. Cell-cycle related regulation of poly(A) polymerase by phosphorylation. Nature 1996; 384: 282–5.
   PubMed Web of Science ®Google Scholar
• Scorilas A, Talieri M, Ardavanis A, et al. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: a new independent prognostic marker in primary breast cancer. Cancer Res 2000; 60: 5427–33.
   PubMed Web of Science ®Google Scholar
• Raju VS, Reddy PR. Androgen regulation of poly(A) polymerase in the ventral prostate of rat. Steroids 1984; 43: 407–14.
   PubMedGoogle Scholar
• Magklara A, Scorilas A, Catalona WJ, et al. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA. Clin Chem 1999; 45: 1960–6.
   PubMed Web of Science ®Google Scholar
• Magklara A, Scorilas A, Stephan C, et al. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue. Urology 2000; 56: 527–32.
   PubMedGoogle Scholar
• Obiezu CV, Scorilas A, Magklara A, et al. Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome. J Clin Endocrinol Metab 2001; 86: 1558–61.
   PubMed Web of Science ®Google Scholar
• Scorilas A, Yu H, Soosaipillai AR, Gregorakis AK, et al. Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy. Clin Chim Acta 2000; 292: 127–38.
   PubMedGoogle Scholar
• Obiezu CV, Giltay EJ, Magklara A, et al. Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals. J Urol 2000; 163: 802–5.
   PubMedGoogle Scholar
• Kokkinopoulos D, Trangas T, Perez S, et al. Dexamethasone caused alterations in poly(A) polymerase levels of a human leukemic cell line. Leuk Res 1986; 10: 1341–5.
   PubMedGoogle Scholar
• Gunderson SI, Vagner S, Polycarpou-Schwarz M, et al. Involvement of the carboxyl terminus of vertebrate poly(A) polymerase in U1A autoregulation and in the coupling of splicing and polyadenylation. Genes Dev 1997; 11: 761–73.
   PubMed Web of Science ®Google Scholar
• Varani L, Gunderson SI, Mattaj IW, et al. The NMR structure of the 38 kDa U1A protein-PIE RNA complex reveals the basis of cooperativity in regulation of polyadenylation by human U1A protein. Nat Struct Biol 2000; 7: 329–35.
   PubMedGoogle Scholar
• Vagner S, Vagner C, Mattaj IW. The carboxyl terminus of vertebrate poly(A) polymerase interacts with U2AF 65 to couple 3'-end processing and splicing. Genes Dev 2000; 14: 403–13.
   PubMed Web of Science ®Google Scholar
• Bond GL, Prives C, Manley JL. Poly(A) polymerase phosphorylation is dependent on novel interactions with cyclins. Mol Cell Biol 2000; 20: 5310–20.
   PubMedGoogle Scholar
• Schul W, van Driel R, de Jong L. A subset of poly(A) polymerase is concentrated at sites of RNA synthesis and is associated with domains enriched in splicing factors and poly(A) RNA. Exp Cell Res 1998; 238: 1–12.
   PubMedGoogle Scholar
• Balatsos NA, Havredaki M, Tsiapalis CM. Early 5-fluorouracil-induced changes of poly(A) polymerase in HeLa and WISH cells. Int J Biol Markers 2000; 15: 294–9.
   PubMedGoogle Scholar
• Cesarman E, Dalla-Favera R, Bentley D, et al. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science 1987; 238: 1272–5.
   PubMed Web of Science ®Google Scholar
• Mowry KL, Steitz JA. Identification of the human U7 snRNP as one of several factors involved in the 3' end maturation of histone premessenger RNA’s. Science 1987; 238: 1682–7.
   PubMed Web of Science ®Google Scholar
• Strub K, Birnstiel ML. Genetic complementation in the Xenopus oocyte: co-expression of sea urchin histone and U7 RNAs restores 3' processing of H3 pre-mRNA in the oocyte. EMBO J 1986; 5: 1675–82.
   PubMedGoogle Scholar
• Scorilas A. Amplification and overexpression of c-myc and c-erbB2 as well as immunoradiometric detection of cathepsin D and enzymatic activity levels of Poly(A)polymerase in breast cancer. Prognostic significance of the the six markers. Athens: NCUA Press, 1996.
   Google Scholar
• Scorilas A, Courtis N, Yotis J, et al. Poly(A)polymerase activity levels in breast tumour cytosols. J Exp Clin Cancer Res 1998; 17: 511–8.
   PubMedGoogle Scholar
• Scorilas A, Karameris A, Arnogiannaki N, et al. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Br J Cancer 2001; 84: 1488–96.
   PubMed Web of Science ®Google Scholar
• Sklavounou A, Chrysomali E, Scorilas A, et al. TNF-alpha expression and apoptosis-regulat-ing proteins in oral lichen planus: a comparative immunohistochemical evaluation. J Oral Pathol Med 2000; 29: 370–5.
   PubMedGoogle Scholar
• Scorilas A, Diamandis EP. Polyvinylamine-streptavidin complexes labeled with a europium chelator: a universal detection reagent for solid-phase time resolved fluorometric applications. Clin Biochem 2000; 33: 345–50.
   PubMed Web of Science ®Google Scholar
• Scorilas A, Bjartell A, Lilja H, et al. Streptavidin-polyvinylamine conjugates labeled with a europium chelate: applications in immunoassay, immunohistochemistry, and microarrays. Clin Chem 2000; 46: 1450–5.
   PubMed Web of Science ®Google Scholar
• Kioka T, Yamagami S, Mui K, et al. Nuclear polyadenylate polymerase activity in the brain of seizure-prone EL mice. Psychiatry Clin Neurosci 1997; 51: 151–5.
   PubMedGoogle Scholar
• Simantov R, Sachs L. Induction of polyadenylate polymerase and differentiation in neuroblas-toma cells. Eur J Biochem 1975; 55: 9–14.
   PubMedGoogle Scholar
• Lindholm DB. Decreased transcription of neuronal polyadenylated RNA during senescence in nuclei from rat brain cortex. J Neurochem 1986; 47: 1503–6.
   PubMedGoogle Scholar
• Courtis NC, Trangas TT, Tsiapalis CM. Increase in the levels of activity of polyadenylic acid-metabolizing enzymes following phytohaemagglutinin stimulation of human lymphocytes. Mol Cell Biochem 1987; 75: 33–42.
   PubMedGoogle Scholar
• Pangalis GA, Trangas T, Papanastasiou CJ, et al. Poly(A)-polymerase activity in chronic lymphocytic leukemia of the B cell type. Acta Haematol 1985; 74: 31–4.
   PubMedGoogle Scholar
• Trangas T, Courtis N, Pangalis GA, et al. Polyadenylic acid polymerase activity in normal and leukemic human leukocytes. Cancer Res 1984; 44: 3691–7.
   PubMedGoogle Scholar
• Sasaki R, Minowada J, Bollum FJ, et al. Polyadenylic acid polymerase activity in chronic myelogenous leukemia. Leuk Res 1990; 14: 273–8.
   PubMedGoogle Scholar
• Balatsos NA, Lallas G, Havredaki M, et al. Drug action on poly(A) polymerase activity and isoforms during U937 cell apoptosis. J Exp Clin Cancer Res 2001; 20: 63–9.
   PubMedGoogle Scholar
• Emmerich B, Pichlmeier R, Ristione R, et al. Protein synthesis in the blood lymphocytes of chronic lymphocytic leukemia and its relationship to prognosis. Klin Wochenschr 1982; 60: 787–93.
   PubMedGoogle Scholar
• Tsiapalis CM. Regulation of mRNA polyadenylation-deadenylation. Mol Biol Rep 1987; 12: 291–8.
   PubMedGoogle Scholar
• Shoker BS, Jarvis C, Clarke RB, et al. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. Am J Pathol 1999; 155: 1811–5.
   PubMed Web of Science ®Google Scholar
• Scorilas A, Yotis J, Stravolemos K, et al. c-erbB-2 overexpression may be used as an independent prognostic factor for breast cancer patients. Anticancer Res 1995; 15: 1543–7.
   PubMedGoogle Scholar
• Scorilas A, Yotis J, Gouriotis D, et al. Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients. Anticancer Res 1993; 13: 1895–900.
   PubMedGoogle Scholar
• Scorilas A, Yotis J, Pateras C, et al. Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis. Clin Cancer Res 1999; 5: 815–21.
   PubMedGoogle Scholar
• Ardavanis A, Scorilas A, Amanatidou A, et al. Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer. Anticancer Res 1997; 17: 1405–9.
   PubMedGoogle Scholar
• Ardavanis A, Scorilas A, Loukeri A, et al. Cathepsin D may help in discriminating node-negative breast cancer patients at risk for local-regional recurrence. Anticancer Res 1998; 18: 2885–90.
   PubMedGoogle Scholar
• Thorpe SM, Christensen IJ, Rasmussen BB, et al. Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal, primary breast cancer. Eur J Cancer 1993; 7: 971–7.
   Google Scholar
• Ardavanis A, Gerakini F, Amanatidou A, et al. Relationships between cathepsin-D, pS2 protein and hormonal receptors in breast cancer cytosols: inconsistency with their established prognostic significance. Anticancer Res 1997; 17: 3665–9.
   PubMed Web of Science ®Google Scholar
• Wahle E, Keller W. The biochemistry of polyadenylation. Trends Biochem Sci 1996; 21: 247–50.
   PubMedGoogle Scholar
• Kleiman FE, Manley JL. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science 1999; 285: 1576–9.
   PubMed Web of Science ®Google Scholar
• Kazazoglou T, Tsiapalis CM, Havredaki M. Polyadenylate polymerase activity in stationary and growing cell cultures. Exp Cell Biol 1987; 55: 164–72.
   PubMedGoogle Scholar
• Jacob ST, Rose KM. Phosphorylation and immunology of poly(A) polymerase. Adv Enzyme Regul 1984; 22: 485–97.
   PubMedGoogle Scholar
• Lopez-Otin C, Diamandis EP. Breast and prostate cancer: an analysis of common epidemio-logical, genetic, and biochemical features. Endocr Rev 1998; 19: 365–96.
   PubMed Web of Science ®Google Scholar
• Scorilas A, Bharaj B, Giai M, et al. Codon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancer. Br J Cancer 2001; 84: 760–7.
   PubMedGoogle Scholar
• Bharaj B, Scorilas A, Diamandis EP, et al. Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate-specific antigen gene promoter. Breast Cancer Res Treat 2000; 61: 111–9.
   PubMedGoogle Scholar
• Scorilas A, Trangas T, Yotis J, et al. Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis. Br J Cancer 1999; 81: 1385–91.
   PubMedGoogle Scholar
• Magklara A, Scorilas A, Lopez-Otin C, et al. Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid. Clin Chem 1999; 45: 1774–80.
   PubMed Web of Science ®Google Scholar
• Scorilas A, Diamandis EP, Levesque MA, et al. Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients. Clin Cancer Res 1999; 5: 1778–85.
   PubMedGoogle Scholar
• Bharaj B, Scorilas A, Giai M, et al. TA repeat polymorphism of the 5alpha-reductase gene and breast cancer. Cancer Epidemiol Biomarkers Prev 2000; 9: 387–93.
   PubMedGoogle Scholar
• Cooper MR. The role of chemotherapy for node-negative breast cancer. Cancer 1991; 67: 1744–7.
   PubMedGoogle Scholar